Lactobacillus Reuteri for Prevention of Necrotizing Enterocolitis in Very Low-birth Weight Infants

NCT01531179 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Necrotizing Enterocolitis
Very Low Birth Weight Infants

Interventions

DRUG: Lactobacillus reuteri
DRUG: Placebo

Sponsor

Zekai Tahir Burak Women's Health Research and Education Hospital